Viewing Study NCT01474551


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-05-29 @ 5:11 AM
Study NCT ID: NCT01474551
Status: TERMINATED
Last Update Posted: 2015-11-18
First Post: 2011-11-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vemurafenib View
None skin cancer View
None Stage IV View
None advanced stage III View
None 11-091 View